You sense something has shifted, sleep, mood, energy, weight, but your annual physical came back "normal." If that gap between how you feel and what the paperwork says has left you frustrated, you are not imagining it, and you are not alone.
The myth: "My yearly checkup covered my hormones"
A routine annual physical is designed to catch broad problems, blood pressure, cholesterol, blood sugar, kidney and liver function, and to update screenings. It is a genuinely useful safety net. But it was never built to characterize the hormonal transition of midlife. Most standard panels do not include the reproductive hormones at all, and when a single hormone is checked, it is often interpreted against reference ranges that assume a stable, non-transitional state.
That matters because perimenopause is defined by *fluctuation*, not a clean before-and-after. The North American Menopause Society and the Endocrine Society describe the menopause transition as a years-long stretch of irregular cycles and swinging hormone levels that can begin in the early-to-mid 40s, sometimes sooner [1][2]. Being 43 or 44 does not make you "too young." It places you squarely in the window where this typically starts.
Why a single FSH snapshot can mislead
The test people most often reach for is FSH (follicle-stimulating hormone). It is intuitive: as the ovaries become less responsive, FSH tends to rise. The problem is timing. During perimenopause, FSH and estradiol can vary dramatically from week to week and even day to day, so one blood draw is a single frame from a moving picture [1][3].
The Stages of Reproductive Aging Workshop (STRAW+10), the widely used staging framework, is explicit that in the early menopause transition, FSH is *variable* and a single value is not a reliable marker of stage [3]. A "normal" FSH drawn on a high-estrogen day can read reassuringly while your symptoms tell a different story. This is a large part of why one basic test can come back "normal" when you don't feel normal.
The clinical guidance follows from this. For women in the typical age range with classic changes, professional societies note that the diagnosis of perimenopause is often made from symptom pattern and menstrual history, not from a lab number [1][2]. Labs still add value, but as one layer of a fuller picture, not a single yes/no gate.
Which markers commonly get skipped
A standard physical rarely maps the systems that perimenopause touches. A more complete baseline review, ordered and interpreted by a licensed provider, often looks beyond a lone FSH to a broader set of markers, considered together and over time. Depending on your history, that broader review can include:
- Thyroid function (TSH, sometimes free T4). Thyroid disorders are common in midlife women and can mimic perimenopausal symptoms, fatigue, weight change, mood shifts, so ruling thyroid in or out matters [4].
- Estradiol and FSH, read in context. Useful as part of a pattern, with the fluctuation caveat above in mind [3].
- Metabolic markers. Fasting glucose and hemoglobin A1c (a 2–3 month average of blood sugar) help characterize metabolic health, which commonly shifts across the transition [5].
- Lipids. The menopause transition is associated with changes in cholesterol and cardiovascular risk factors, which is why the American College of Cardiology and American Heart Association highlight this window for cardiovascular attention [6].
- Iron studies (ferritin) and CBC. Heavy or irregular bleeding is common in perimenopause and can affect iron stores.
- Vitamin D.
None of these are self-diagnostic. The point is that any one number in isolation, especially a single FSH, tells you far less than a coordinated panel interpreted alongside how you actually feel.
Source: [4] Hypothyroidism (Underactive Thyroid) — NIDDK, National Institutes of Health, [5] Diabetes Tests & Diagnosis (A1C) — NIDDK, National Institutes of Health
% A1C · marker = Diagnostic cutoff
Source: [5] Diabetes Tests & Diagnosis (A1C) — NIDDK, National Institutes of Health
What "a fuller baseline" actually does for you
A baseline is not a program you have to sign up for. It is a reference point. Because perimenopause is a moving target, the real value is in establishing where you are now so that changes can be tracked over the coming years, rather than reacting to one snapshot.
That reframing also answers a fair worry: a good process should *listen and measure first*, then discuss options, not lead with a pill. Whether any treatment is appropriate, including menopausal hormone therapy, is an individualized decision that a licensed provider makes with you, weighing your symptoms, history, and preferences against current guidelines [2]. This article is educational and is not medical advice.
"Too young" is usually the wrong frame
If you've been told to "come back in a few years," it's worth knowing what the staging literature actually says. The transition can span several years before a final period, and symptoms frequently arrive while cycles are still occurring [1][3]. Being early is not the same as being wrong about your own body. A serious evaluation takes the symptom pattern seriously *and* uses labs intelligently, understanding their limits.
Source: [3] Harlow SD, et al. Executive summary of the Stages of Reproductive Aging Workshop +10 (STRAW+10).
Where Velri fits
Velri is a technology and coordination company, not a medical practice. Velri does not provide medical care or guarantee any prescription. What Velri can do is coordinate the pieces that are otherwise hard to assemble: help arrange a comprehensive lab baseline, connect you with an independent, licensed provider who reviews those results alongside your history and how you feel, and, if that provider determines a prescription is appropriate, coordinate fulfillment through an independent, licensed pharmacy.
The sequence is deliberate, data first, conversation second, options only after a provider has mapped your picture. Any treatment decision, including whether hormone therapy of any kind is suitable, rests entirely with the independent provider.
If compounded medications are ever discussed as part of your care: Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
This content is educational and is not medical advice, diagnosis, or treatment. Talk with a licensed provider about your individual situation.
